de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...
In a significant contribution to Brain Medicine's Seymour Reichlin Centenary Festschrift, renowned neuroendocrinologist Dr. Philip W. Gold synthesizes decades of research revealing depression's ...
A new digital health intervention, developed over a decade of research, uses a gamified app to help reduce depressive symptoms by disrupting ruminative thought patterns.